- Home
- HCWB vs PMEC Comparison
HCWB vs PMEC Comparison
Compare HCWB & PMEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- PMEC
- Stock Information
- Founded
- HCWB 2018
- PMEC 1984
- Country
- HCWB United States
- PMEC Singapore
- Employees
- HCWB N/A
- PMEC N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- PMEC
- Sector
- HCWB Health Care
- PMEC
- Exchange
- HCWB Nasdaq
- PMEC Nasdaq
- Market Cap
- HCWB 26.6M
- PMEC 29.3M
- IPO Year
- HCWB 2021
- PMEC 2023
- Fundamental
- Price
- HCWB $0.31
- PMEC $0.76
- Analyst Decision
- HCWB
- PMEC
- Analyst Count
- HCWB 0
- PMEC 0
- Target Price
- HCWB N/A
- PMEC N/A
- AVG Volume (30 Days)
- HCWB 96.6K
- PMEC 57.5K
- Earning Date
- HCWB 11-19-2024
- PMEC 12-26-2024
- Dividend Yield
- HCWB N/A
- PMEC N/A
- EPS Growth
- HCWB N/A
- PMEC N/A
- EPS
- HCWB N/A
- PMEC N/A
- Revenue
- HCWB $3,922,670.00
- PMEC $72,524,000.00
- Revenue This Year
- HCWB N/A
- PMEC N/A
- Revenue Next Year
- HCWB N/A
- PMEC N/A
- P/E Ratio
- HCWB N/A
- PMEC N/A
- Revenue Growth
- HCWB 2.82
- PMEC 5.07
- 52 Week Low
- HCWB $0.28
- PMEC $0.49
- 52 Week High
- HCWB $1.93
- PMEC $4.15
- Technical
- Relative Strength Index (RSI)
- HCWB 26.31
- PMEC 50.46
- Support Level
- HCWB $0.42
- PMEC $0.67
- Resistance Level
- HCWB $0.50
- PMEC $0.78
- Average True Range (ATR)
- HCWB 0.04
- PMEC 0.06
- MACD
- HCWB -0.01
- PMEC -0.00
- Stochastic Oscillator
- HCWB 4.39
- PMEC 52.14
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.